title: [What is the future for treating scars?].
authors.affiliation: Unité fonctionnelle plaies et cicatrisations, département de Chirurgie, Hôpital Lapeyronie, CHRU Montpellier, 71 avenue du Doyen Giraud, 34295 Montpellier, France. Iteot@aol.com
authors.forename: Luc
authors.initials: L
authors.lastname: Téot
mesh_terms: D000287:Administration, Topical; D050256:Antimitotic Agents / Q000008:administration & dosage; D002921:Cicatrix / Q000451:nursing* / Q000503:physiopathology / Q000628:therapy*; D005472:Fluorouracil / Q000008:administration & dosage; D005544:Forecasting; D005602:France; D005663:Furans / Q000008:administration & dosage; D006801:Humans; D007659:Ketones / Q000008:administration & dosage; D054843:Negative-Pressure Wound Therapy; D012828:Silicones / Q000008:administration & dosage; D012867:Skin / Q000503:physiopathology; D053782:Transforming Growth Factor beta3 / Q000008:administration & dosage; D000095662:Polyether Polyketides
chemical_list: D050256:Antimitotic Agents; D005472:Fluorouracil; D005663:Furans; D007659:Ketones; D012828:Silicones; D053782:Transforming Growth Factor beta3; C509044:TGFB3 protein, human; C490954:eribulin; D000095662:Polyether Polyketides